Distinct interactions of 2′- and 3′-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor

Biochemical Pharmacology

Volumn 78, Issue 3, 2009, Pages 224-230

  Suryanarayana, Srividya ^a   Wang, Jenna L ^a   Richter, Mark ^a   Shen, Yuequan ^b   Tang, Wei Jen ^c   Lushington, Gerald H ^a   Seifert, Roland ^d  

^a UNIVERSITY OF KANSAS   (United States)

^b NANKAI UNIVERSITY   (China)

^c UNIVERSITY OF CHICAGO   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Calmodulin; Edema factor; Fluorescence spectroscopy; MANT nucleotide; Molecular modelling

Indexed keywords

2' O (N METHYL)ANTHRANILOYL 3' DEOXY ADENOSINE TRIPHOSPHATE; 3' O (N METHYL)ANTHRANILOYL 2' DEOXY ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE TOXIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; GUANOSINE TRIPHOSPHATE; NUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS ANTHRACIS; CASE REPORT; CATALYSIS; CONTROLLED STUDY; ENZYME INHIBITION; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; ISOMER; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RACEMIC MIXTURE;

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ANTHRANILIC ACIDS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GUANOSINE TRIPHOSPHATE; ISOMERISM; MODELS, MOLECULAR;

EID: 67349287667     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.04.006     Document Type: Article

References (24)

1. Jedrzejas M.J. The structure and function of novel proteins of Bacillus anthracis and other spore-forming bacteria: development of novel prophylactic and therapeutic agents. Crit Rev Biochem Mol Biol 37 (2002) 339-373
2. Drum C.L., Yan S.Z., Bard J., Shen Y.Q., Lu D., Soelaiman S., et al. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415 (2002) 396-402
3. Shen Y., Lee Y.S., Soelaiman S., Bergson P., Lu D., Chen A., et al. Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J 21 (2002) 6721-6732
4. Shen Y., Zhukovskaya N.L., Zimmer M.I., Soelaiman S., Bergson P., Wang C.R., et al. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci USA 101 (2004) 3242-3247
5. Taha H.M., Schmidt J., Göttle M., Suryanarayana S., Shen Y., Tang W.J., et al. Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2′(3′)-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides. Mol Pharmacol 75 (2009) 693-703
6. Gille A., Lushington G.H., Mou T.C., Doughty M.B., Johnson R.A., and Seifert R. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides. J Biol Chem 279 (2004) 19955-19969
7. Gille A., and Seifert R. 2′(3′)-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. J Biol Chem 278 (2003) 12672-12679
8. Mou T.C., Gille A., Fancy D.A., Seifert R., and Sprang S.R. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-triphosphate. J Biol Chem 280 (2005) 7253-7261
9. Mou T.C., Gille A., Suryanarayana S., Richter M., Seifert R., and Sprang S.R. Broad specificity of mammalian adenylyl cyclase for interaction with 2′,3′-substituted purine- and pyrimidine-nucleotide inhibitors. Mol Pharmacol 70 (2006) 878-886
10. Jameson D.M., and Eccleston J.F. Fluorescent nucleotide analogs: synthesis and applications. Methods Enzymol 278 (1997) 363-390
11. Hiratsuka T. New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes. Biochim Biophys Acta 742 (1983) 496-508
12. SYBYL 7.2 (2006), The Tripos Associates, St. Louis, MO, USA
13. Gasteiger J., and Marsili M. Iterative partial equalization of orbital electronegativity: a rapid access to atomic charges. Tetrahedron 36 (1980) 3219-3228
14. Clark M., Cramer III R.D., and Van Opdenbosch N. Validation of the general purpose Tripos 5.2 force field. J Comput Chem 10 (1989) 982-1012
15. Rarey M., Kramer B., Lengauer T., and Klebe G.A. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261 (1996) 470-489
16. Ortiz A.R., Pisabarro M.T., Gago F., and Wade R.C. Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 38 (1995) 2681-2691
17. SIMCA-P, Umereics AB, July 2001.
18. Lakowicz J.R. Principles of fluorescence spectroscopy (1999), Kluwer Academic/Plenum, New York
19. Göttle M., Dove S., Steindel P., Shen Y., Tang W.J., Geduhn J., et al. Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides. Mol Pharmacol 72 (2007) 526-535
20. Laux W.H., Pande P., Shoshani I., Gao J., Boudou-Vivet V., Gosselin G., et al. Pro-nucleotide inhibitors of adenylyl cyclases in intact cells. J Biol Chem 279 (2004) 13317-13332
21. Göttle M, Geduhn J, König B, Gille A, Höcherl K, Seifert R. Characterization of mouse heart adenylyl cyclase. J Pharmacol Exp Ther; in press.
22. Spangler C.M., Spangler C., Göttle M., Shen Y., Tang W.J., Seifert R., et al. A fluorimetric assay for real-time monitoring of adenylyl cyclase activity based on terbium norfloxacin. Anal Biochem 381 (2008) 86-93
23. Rensland H., Lautwein A., Wittinghofer A., and Goody R.S. Is there a rate-limiting step before GTP cleavage by H-ras p21?. Biochemistry 30 (1991) 11181-11185
24. N-ras catalyzed by GAP: studies with a fluorescent GTP analogue. Biochemistry 32 (1993) 7451-7459